 Detection of tumor presence will be compared in urine specimens undergoing mutational analysis and the current standard of treatment cytology and cystoscopy together. As cytology is not performed on all patients, fewer urine specimens are expected in the cytology and cystoscopy group than in the mutational analysis group. Therefore a comparative analysis between these two groups will be performed using an analysis of variance ANOVA test where significance will be set at p0.05. 